METASTATIC/LOCALLY PANCREATIC DUCTAL ADENOCARCINOMA

Clinical trials for METASTATIC/LOCALLY PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC/LOCALLY PANCREATIC DUCTAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC/LOCALLY PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug targets 'Undruggable' cancer mutation in major trial

Disease control Recruiting now

This study is testing an experimental drug called ASP3082 in people with advanced lung or pancreatic cancer that has a specific genetic change called KRAS G12D. The trial aims to see how well the drug works to control the cancer and to understand how the cancer might become resis…

Matched conditions: METASTATIC/LOCALLY PANCREATIC DUCTAL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

METASTATIC/LOCALLY PANCREATIC DUCTAL ADENOCARCINOMA

Get alerted when new METASTATIC/LOCALLY PANCREATIC DUCTAL ADENOCARCINOMA trials appear

New drug targets 'Undruggable' cancer mutation in major trial